US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:100.18

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sonic Healthcare Updates Share Registry Address for Investors

HealthCo Healthcare & Wellness REIT issues 2026 annual report to unitholders

Ramsay Health Care sets 2026 AGM and flags Ramsay Santé demerger vote

Viemed President Adopts Structured Share Sale Plan Under Rule 10b5-1

Ramsay Health Care Publishes 2026 Corporate Governance Statement

Ramsay Health Care Sets Out Strategy and Performance in 2026 Annual Report

Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME)

22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule

Healthcare Stocks Rise Despite Broad Market Selloff

Prime Medicine Shares Jump on FDA Clearance for Investigational New Drug Application

Prime Medicine announces FDA clearance of IND application for PM647

Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency

Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test

Health Care Roundup: Market Talk

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Teladoc (TDOC) and Zimmer Biomet Holdings (ZBH)

Reliability Launches Healthcare-Focused Workplace Solutions Subsidiary

Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)

Pomdoctor Showcases Integrated ‘Hardware + AI + Payment’ Model to Redefine Digital Healthcare Infrastructure

TD ups Grail approval probability to 95% after panel vote

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Market Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.055472560797593,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.055472560797593,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":100.18,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670441970","title":"Sonic Healthcare Updates Share Registry Address for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670441970","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670441970?lang=en_us&edition=fundamental","pubTime":"2026-09-25 08:20","pubTimestamp":1790295616,"startTime":"0","endTime":"0","summary":"Sonic Healthcare Limited ( ($AU:SHL) ) just unveiled an announcement. Sonic Healthcare has notified the market that, effective 30 October 2026, the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-updates-share-registry-address-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sonic-healthcare-updates-share-registry-address-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4588","ISBC","LABU","BK4581","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670678416","title":"HealthCo Healthcare & Wellness REIT issues 2026 annual report to unitholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2670678416","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670678416?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:14","pubTimestamp":1790291676,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare & Wellness REIT ( ($AU:HCW) ) has shared an update. HealthCo Healthcare & Wellness REIT has released its annual report for the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-issues-2026-annual-report-to-unitholders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthco-healthcare-wellness-reit-issues-2026-annual-report-to-unitholders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BPRE","RJMG","MDIV","LU0029874061.USD","BK4137","RNTY","XLV","BK4585","BK4581","XBI","BK4588","HCSG","LU0128526141.USD","DFRA","YLDW","LABU","IVRA","REIT","PSCF","IQRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670416988","title":"Ramsay Health Care sets 2026 AGM and flags Ramsay Santé demerger vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2670416988","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670416988?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:12","pubTimestamp":1790291573,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has shared an update. Ramsay Health Care Limited has announced that its 2026 Annual General Meeting will be held o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-sets-2026-agm-and-flags-ramsay-sante-demerger-vote?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-sets-2026-agm-and-flags-ramsay-sante-demerger-vote?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4588","BK4581","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670674416","title":"Viemed President Adopts Structured Share Sale Plan Under Rule 10b5-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2670674416","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670674416?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:01","pubTimestamp":1790290907,"startTime":"0","endTime":"0","summary":"Viemed Healthcare ( ($VMD) ) has issued an update. Viemed Healthcare has disclosed that its president, Michael Moore, has put in place an automatic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viemed-president-adopts-structured-share-sale-plan-under-rule-10b5-1?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viemed-president-adopts-structured-share-sale-plan-under-rule-10b5-1?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LABU","BK4581","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670805416","title":"Ramsay Health Care Publishes 2026 Corporate Governance Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2670805416","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670805416?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:00","pubTimestamp":1790290801,"startTime":"0","endTime":"0","summary":"An update from Ramsay Health Care ( ($AU:RHC) ) is now available. Ramsay Health Care has released its 2026 Corporate Governance Statement along wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-publishes-2026-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-publishes-2026-corporate-governance-statement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670416826","title":"Ramsay Health Care Sets Out Strategy and Performance in 2026 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2670416826","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670416826?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:59","pubTimestamp":1790290792,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has issued an update. Ramsay Health Care has released its 2026 Annual Report, detailing governance, financial perf...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-sets-out-strategy-and-performance-in-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-sets-out-strategy-and-performance-in-2026-annual-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LABU","BK4585","XBI","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670151394","title":"Analysts Are Bullish on Top Healthcare Stocks: Arcus Biosciences (RCUS), Prime Medicine, Inc. (PRME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670151394","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670151394?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:50","pubTimestamp":1790286610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcus Biosciences (RCUS) and Prime Medicine, Inc. (P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-arcus-biosciences-rcus-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-arcus-biosciences-rcus-prime-medicine-inc-prme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","PRME","LU0128526141.USD","LU0029874061.USD","XLV","BK4585","BK4139","RCUS","BK4581","XBI","BK4588","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670821415","title":"22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2670821415","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670821415?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:42","pubTimestamp":1790286120,"startTime":"0","endTime":"0","summary":"22nd Century Group Calls on HHS Secretary Kennedy, Acting FDA Commissioner Diamantas and CTP Director Koplow to Enact and Implement the Reduced Nicotine Content Standard Administration’s Reported Move","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368790/0/en/22nd-century-group-urges-policymakers-and-fda-to-enact-and-implement-the-reduced-nicotine-content-standard-citing-years-without-a-final-rule.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNBKA","LABU","BK4588","SMP","BK4124","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670641370","title":"Healthcare Stocks Rise Despite Broad Market Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2670641370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670641370?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:34","pubTimestamp":1790285640,"startTime":"0","endTime":"0","summary":"The healthcare sector was one of the few to escape another losing day in U.S. stocks.Grail received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test. The cancer-detection company said the FDA's medical devices advisory committee voted to greenlight a premarket approval application for Galleri. The FDA is expected to make its final ruling on Galleri's premarket approval in the coming months.Interest in natural fibers such as cotton and wool is rising as people seek clothing that's safe and sustainable. But while natural fibers in many cases may use fewer chemicals than synthetics, a body of research is challenging whether they deserve a free pass. Scientists are finding chemicals in cotton and other natural-fiber clothing that, in studies not specific to apparel, have been shown to penetrate skin and cause health effects at sufficient exposures. Natural-fiber garments also shed microfibers that have","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0128526141.USD","XLV","BK4137","BK4585","HCSG","LABU","LU0029874061.USD","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670139964","title":"Prime Medicine Shares Jump on FDA Clearance for Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2670139964","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670139964?lang=en_us&edition=fundamental","pubTime":"2026-09-25 05:08","pubTimestamp":1790284080,"startTime":"0","endTime":"0","summary":"Shares of Prime Medicine jumped after the biotechnology company said the Food and Drug Administration cleared its investigational new drug application for PM647 to treat the genetic disease Alpha-1 Antitrypsin Deficiency.Shares were up 13% to $3.47 in after-hours trading on Thursday after closing down 1.9% at $3.07. Through the close, the stock had fallen 12% this year.The company said the FDA's clearance means it can initiate clinical studies in the U.S.\"FDA clearance of the PM647 IND is an important milestone for Prime Medicine, marking continued momentum across our liver franchise,\" Chief Executive Officer Allan Reine said. \"PM647 has the potential to change how AATD is treated, offering a Prime Editing-based approach that moves beyond protein replacement and targets the root cause of disease.\"","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4588","PRME","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670629418","title":"Prime Medicine announces FDA clearance of IND application for PM647","url":"https://stock-news.laohu8.com/highlight/detail?id=2670629418","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670629418?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:05","pubTimestamp":1790280337,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) announced that the FDA has cleared the company’s Investigational New Drug, or IND, application for PM647, an investigational ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-announces-fda-clearance-of-ind-application-for-pm647-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-announces-fda-clearance-of-ind-application-for-pm647-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","IND","PRME","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670183504","title":"Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2670183504","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670183504?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:01","pubTimestamp":1790280060,"startTime":"0","endTime":"0","summary":"-- Clearance highlights continued execution, modularity and momentum across Prime Medicine’s liver franchise, building on recent regulatory clearances for PM577a -- -- Initial clinical data expected i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/24/3368730/0/en/prime-medicine-announces-u-s-fda-clearance-of-investigational-new-drug-application-for-pm647-in-alpha-1-antitrypsin-deficiency.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492599","title":"Grail Shares Gain as FDA Panel Votes to Support Cancer Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492599","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492599?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:22","pubTimestamp":1790266920,"startTime":"0","endTime":"0","summary":"Shares of Grail rose after the healthcare company said a U.S. regulatory committee voted to approve its Galleri multi-cancer early detection test.The stock was up 5.6% at $114.59 as of midday Thursday. Shares have risen 34% this year.The company on Wednesday said a panel on the Food and Drug Administration's Medical Devices Advisory Committee voted to approve its premarket approval application for Galleri.The panel voted seven to two with one abstention that the test's benefits outweigh its risks, six to four that the test was effective, and unanimously in support of its safety.\"Today's vote reinforces the strength of Galleri's clinical evidence. We believe the panel's recommendations reaffirm a high evidence bar that GRAIL has set for a multi-cancer early detection test,\" Grail Chief Executive Josh Ofman said. \"GRAIL is committed to working with the FDA as it completes its review of Galleri, the first PMA submission for a multi-cancer early detection test.\"Galleri received a breakthro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LABU","GRAL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670513492","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2670513492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670513492?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:20","pubTimestamp":1790266800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1032 ET - UCB's portfolio offers growth potential into the next ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648001328.SGD","FNCL","LU0683600562.USD","FTXO","XLF","XLV","LABU","LU0477156797.USD","LU2129689605.HKD","IE00B1BXHZ80.USD","IE0034235188.USD","LU1291159041.SGD","LU1894683264.USD","LU0321505868.SGD","LU2265009873.SGD","LU1496350502.SGD","LU2596442595.SGD","LU0106831901.USD","LU0098860793.USD","UYG","LU0234572021.USD","LU1280957306.USD","LU0149725797.USD","LU0417517546.SGD","LU1035773651.USD","TFNS","LU0868494617.USD","BK4553","LU0320765489.SGD","KBWB","LU1069347547.HKD","LU0477156953.USD","LU0980610538.SGD","BAC","IE00BLSP4239.USD","IYG","LU0170899867.USD","XBI","LU0130103400.USD","TCAF","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","IYF","LU0256863811.USD","VFH","LU0234570918.USD","LU1791807156.HKD","LU1804176565.USD","LU1880398471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4196","LFSC","BK4551","BK4082","ABT","LU0122379950.USD","TMED","LABU","LU1061106388.HKD","BK4585","LU2089984988.USD","FFOX","LU1721429402.USD","BK4588","LU1989763690.USD","SGXZ23171101.USD","LU0889565916.HKD","SG9999004303.SGD","LU2112291526.USD","BK4581","GNMX","LU1691799644.USD","SGXZ41872573.SGD","LU0868494617.USD","PJP","LU1670627923.USD","BK4568","LU0320765489.SGD","IE0002141913.USD","LU2468319806.SGD","GRAL","GH","SG9999002232.USD","EKG","HELX","LU1721429741.USD","BK4139","SG9999002224.SGD","LU2237957811.SGD","LU0289739699.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","PTH","GNOM","LU0882574055.USD","BK4535","IHI","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (ARCT), Teladoc (TDOC) and Zimmer Biomet Holdings (ZBH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499173?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:20","pubTimestamp":1790259612,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arcturus Therapeutics (ARCT), Teladoc (TDOC) and Zimmer Biomet Ho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-teladoc-tdoc-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcturus-therapeutics-arct-teladoc-tdoc-and-zimmer-biomet-holdings-zbh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z3581.USD","LU0211327993.USD","LU0889566641.SGD","BK4139","TDOC","LU0211328371.USD","ZBH","LU1267930490.SGD","BK4504","BK4588","LABU","LU0130102774.USD","IE0002270589.USD","LU0029874061.USD","LU0708994859.HKD","BK4585","LU0128526141.USD","LU0477156953.USD","LU1201861249.SGD","LU0792757196.USD","BK4167","LU0128525929.USD","XBI","LU0130517989.USD","LU1861558580.USD","XLV","LU1267930573.SGD","LU0310800379.SGD","LU0029864427.USD","BK4137","IE00B7SZLL34.SGD","LU0006061336.USD","BK4082","BK4581","BK4567","LU0980610538.SGD","ARCT","LU0648001328.SGD","LU1861559042.SGD","BK4534","LU0310799852.SGD","BK4548","HCSG","LU1267930813.SGD","IE00B19Z3B42.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669991774","title":"Reliability Launches Healthcare-Focused Workplace Solutions Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2669991774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669991774?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:18","pubTimestamp":1790259491,"startTime":"0","endTime":"0","summary":"Reliability ( ($RLBY) ) has issued an update. On September 24, 2026, Reliability Incorporated launched Reliability Workplace Solutions, LLC, a whol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/reliability-launches-healthcare-focused-workplace-solutions-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/reliability-launches-healthcare-focused-workplace-solutions-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","LU0128526141.USD","BK4581","BK4588","LU0029874061.USD","HCSG","XBI","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669919495","title":"Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669919495","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669919495?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:30","pubTimestamp":1790256610,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on NanoViricides (NNVC) and Ionis Pharmaceuticals (IONS). NanoVirici...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nanoviricides-nnvc-and-ionis-pharmaceuticals-ions-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","XBI","BK4585","BK4581","HCSG","BK4139","XLV","LU0128526141.USD","LU0029874061.USD","LABU","BK4588","BK4137","NNVC","IONS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669949594","title":"Pomdoctor Showcases Integrated ‘Hardware + AI + Payment’ Model to Redefine Digital Healthcare Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669949594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669949594?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:27","pubTimestamp":1790256426,"startTime":"0","endTime":"0","summary":"PomDoctor Ltd. Unsponsored ADR ( ($POM) ) has shared an announcement. On September 24, 2026, Pomdoctor Limited highlighted its differentiated “hard...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pomdoctor-showcases-integrated-hardware-ai-payment-model-to-redefine-digital-healthcare-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pomdoctor-showcases-integrated-hardware-ai-payment-model-to-redefine-digital-healthcare-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AIPO","ARMH","APIE","XBI","DINT","BK4581","LU0128526141.USD","VTHR","BK4585","DIVL","HCSG","CVY","XLV","CHAT","AADR","ARTY","QTOC","LU0029874061.USD","SAPH","LABU","BK4137","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669349596","title":"TD ups Grail approval probability to 95% after panel vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2669349596","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669349596?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:20","pubTimestamp":1790256057,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Dan Brennan views the end result of the FDA panel meeting as solid for Grail (GRAL). The panel voted 7-2 with in favor of Galleri’...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/td-ups-grail-approval-probability-to-95-after-panel-vote-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/td-ups-grail-approval-probability-to-95-after-panel-vote-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","GRAL","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":13,"totalSize":396,"code":"91000000","status":"200"}]}}